ac chemotherapy breast cancer

Release time ：Dec-11,2024

AC chemotherapy, a standard treatment for breast cancer, combines doxorubicin, an anthracycline, with cyclophosphamide. While effective, it can lead to various side effects.

Firstly, patients often experience nausea and vomiting, among the most common side effects. To mitigate these, physicians typically prescribe antiemetic medications. Hair loss, another widespread issue, is usually temporary, with regrowth occurring post-treatment. Fatigue, another prevalent side effect, may stem from the stress chemotherapy places on the body, leading to increased tiredness and the need for additional rest.

More severe side effects can include cardiac damage; prolonged anthracycline use may heighten the risk of heart disease. Consequently, patients undergoing AC chemotherapy require regular cardiac function assessments. Chemotherapy may also lower white blood cell counts, increasing the susceptibility to infections. To preempt infections, patients must maintain proper personal hygiene and avoid contact with ill individuals.

During AC chemotherapy, it is crucial for patients to closely monitor their health and maintain open communication with their healthcare team. Any new symptoms or exacerbation of side effects should be promptly reported. Additionally, following the doctor's advice on adopting a healthy lifestyle—inclusive of a balanced diet, moderate exercise, and adequate rest—can help alleviate the discomforts of chemotherapy. In conclusion, while AC chemotherapy may induce side effects, with proper guidance from medical professionals, patients can manage these challenges through appropriate strategies and adjustments.